Melinda S. Yates - Concepedia

Author

Melinda S. Yates

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Lu, Karen H., M. Yates, Maya Yates, Melinda S Yates, Melinda S. Yates, Melinda Sue YATES, Melinda Sue Yates, Melinda Yates, Pamela Soliman, Yates, Melinda S.

157

Publications

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Johns Hopkins University Dartmouth College Johns Hopkins Medicine Tohoku University

About

Melinda S. Yates is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, obstetrics, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	2K
2	Health Sciences	2	2	286
3	Natural Sciences	2	2	36
4	Public Health	2	2	97
5	Education	1	1	26

Melinda S. Yates

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Nrf2-dependent protection from LPS induced inflammatory response and mortality by CDDO-Imidazolide Rajesh K. Thimmulappa, Catherine Scollick, Kassim Traore, Biochemical and Biophysical Research Communications InflammationCytokineAnti-inflammatoryAutoimmune DiseaseMedicine	2006	347
Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice Thomas E. Sussan, Tirumalai Rangasamy, David J. Blake, Proceedings of the National Academy of Sciences AsthmaLipid PeroxidationImmunologyCell DeathCigarette Smoke-induced Emphysema	2008	343
Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma Brian M. Slomovitz, Yunyun Jiang, Melinda S. Yates, Journal of Clinical Oncology	2015	312
Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes Melinda S. Yates, Masafumi Tauchi, Fumiki Katsuoka, Molecular Cancer Therapeutics	2007	292
Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-Imidazolide Soona Shin, Junko Wakabayashi, Melinda S. Yates, European Journal of Pharmacology ObesityMetabolic SyndromeHigh-fat Diet-induced ObesitySynthetic Triterpenoid Cddo-imidazolideBiochemistry	2009	273
Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice Melinda S. Yates, Quynh T. Tran, Patrick M. Dolan, Carcinogenesis	2009	261
Potent Protection against Aflatoxin-Induced Tumorigenesis through Induction of Nrf2-Regulated Pathways by the Triterpenoid 1-[2-Cyano-3-,12-Dioxooleana-1,9(11)-Dien-28-Oyl]Imidazole Melinda S. Yates, Mi-Kyoung Kwak, Patricia A. Egner, Cancer Research	2006	189
Genetic or Pharmacologic Amplification of Nrf2 Signaling Inhibits Acute Inflammatory Liver Injury in Mice William O. Osburn, Melinda S. Yates, Patrick D. Dolan, Toxicological Sciences	2008	154
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy Christopher P. Vellano, Michael G. White, Miles C. Andrews, Nature Hormonal ReceptorBreast CancerPharmacotherapyEndocrinologyMedicine	2022	124
Immune Microenvironment in Microsatellite-Instable Endometrial Cancers: Hereditary or Sporadic Origin Matters Janelle B. Pakish, Qian Zhang, Zhongyuan Chen, Clinical Cancer Research	2017	122

Page 1